David Tuck
VA Boston Healthcare System(US)Philadelphia VA Medical Center(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, DNA Repair Mechanisms, Histone Deacetylase Inhibitors Research, Epigenetics and DNA Methylation, Gene expression and cancer classification
Most-Cited Works
- → Overcoming Therapeutic Resistance in HER2-Positive Breast Cancers with CDK4/6 Inhibitors(2016)478 cited
- → MSVM-RFE: extensions of SVM-RFE for multiclass gene selection on DNA microarray data(2007)255 cited
- → Macrophages Directly Contribute to the Exaggerated Inflammatory Response in Cystic Fibrosis Transmembrane Conductance Regulator−/− Mice(2008)209 cited
- → Loss of the retinoblastoma binding protein 2 (RBP2) histone demethylase suppresses tumorigenesis in mice lackingRb1orMen1(2011)166 cited
- → Dual HDAC and PI3K Inhibitor CUDC-907 Downregulates MYC and Suppresses Growth of MYC-dependent Cancers(2016)146 cited
- → CUDC-907 in relapsed/refractory diffuse large B-cell lymphoma, including patients with MYC-alterations: results from an expanded phase I trial(2017)136 cited